Yahoo! Finance: Commodity News
SAN DIEGO----Metabasis Therapeutics, Inc. announced today that Mark Erion, PhD, the Company‚??s president, chief executive officer and chief scientific officer as well as a member of its board of directors, has resigned as an officer and director of the Company effective October 31, 2009.
complete story here...
Highly recommended services:
Macro Millionaire - World-class advisory from "Mad Hedge Fund Trader" John Thomas, terrific record of wins
Crash Trader - Greg Roy, the "Rain Man" trader, protects you from market crashes by playing the short side
Biotech Breakout Trader - Mark Messier profits from biotech stocks, by taking advantage of "stupid" traders